Stark Compliance Is Not Enough: OIG Reemphasizes AKS Risk Beyond Fair Market Value
In a recent update that should command the attention of healthcare providers, compliance officers, and healthcare counsel alike, the U.S. Department of Health and Human Services’ Office of Inspector General (OIG) issued two new FAQs emphasizing its view that compliance with the Stark Law and adherence to fair market value (FMV) principles, standing alone, do […]
Read More